Back to Search
Start Over
Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19
Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19
- Source :
- Journal of Pediatric Hematology/Oncology
- Publication Year :
- 2020
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2020.
-
Abstract
- Relapse of infection due to SARS-CoV-2 has been rarely described and there is little guidance regarding the management of such cases in immunocompromised hosts. We present a case of an adolescent female with B-cell acute lymphoblastic leukemia hospitalized multiple times for symptomatic SARS-CoV-2 infection who was safely treated with 2 courses of remdesivir (RDV) and has had no additional readmissions to date. Though additional studies are needed to confirm the safety and efficacy of an additional course of RDV in the setting of relapsed or prolonged severe COVID-19, our observations suggest that a second course of RDV may be considered.
- Subjects :
- 2019-20 coronavirus outbreak
Pediatrics
medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
business.industry
Lymphoblastic Leukemia
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
MEDLINE
Hematology
03 medical and health sciences
Pediatric patient
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Pediatrics, Perinatology and Child Health
medicine
Pediatrics, Perinatology, and Child Health
business
030215 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 10774114
- Database :
- OpenAIRE
- Journal :
- Journal of Pediatric Hematology/Oncology
- Accession number :
- edsair.doi.dedup.....0afeb0a0e00826d4a1a5aa3eef2be1a9
- Full Text :
- https://doi.org/10.1097/mph.0000000000002014